Home / Online GXP courses / Pharmacovigilance / Management of Drug Safety Concern Through a Pharmacovigilance Steering Committee
Successful completion provides learners with a dated, traceable and downloadable certificate for the course :
Each certificate is CPD/CEU accredited and 21 CFR PART 11 compliant. Certificates validity can be checked online through our certificate online checker. They can also be shared on Linkedin.
The understanding of all drugs being potential poisons is not new to anyone in the pharmaceutical industry. Even at therapeutic doses, some medications are not selective enough in their pharmacology and often interfere with surrounding organs and systems. Pharmacovigilance is that construct that allows for the monitoring of a new pharmaceutical substance or device once it has been released into the market.
When properly implemented, it should reveal adverse reactions and provide information over a timeline that helps prescribers make better decisions concerning the use of the given agent. This course exposes students to the origin of pharmacovigilance and the key players at the global and local levels.
In this course, we provide a synthesis of the topic through an interactive online experience. This material was built by a team of Regulatory Affairs Experts with a Qualification from Northeastern University, Boston, piloted by a Senior Member able to articulate theory with practice.
Introduction
Lesson 1: Historical Perspectives of WHO Drug Safety Management
Lesson 2: Current Practices of Pharmacovigilance
Lesson 3: Partners in Pharmacovigilance
Lesson 4: Drug Regulation Under Pharmacovigilance
Lesson 5: Pharmacovigilance and International Health
Lesson 6: Future Challenges and Drug Safety Considerations
Conclusion
Glossary
Definitions
Quiz
$60.00 / year
$60.00 / year
© GxP Training 2021